Pharmaceuticals
-
Open Orphan primed to support coronavirus vaccine work after bringing in world-leading experts (ORPH)
-
Open Orphan brings in hVIVO founder Prof. John Oxford to head up coronavirus committee (ORPH)
-
Coronavirus test maker Novacyt rockets 900% but investors get sinking feeling (NCYT)
-
VIDEO: Open Orphan’s Cathal Friel details ambitious 2020 plans following £5.3m raise in exclusive presentation (ORPH)
-
Open Orphan expects profits within months as it plans role in coronavirus treatment (ORPH)
Open Orphan’s (LSE:ORPH) exec chair has said he “could not have been happier” with the pharma firm’s recent £5.3 million placing, claiming the...
-
Cathal Friel hails “once in a lifetime” opportunity as Open Orphan/hVIVO merger passes (ORPH)
-
Open Orphan signs key contract with Pennsylvania’s SFA Therapeutics (ORPH)
-
Open Orphan signs five clients to Genomic Health Data platform ahead of launch (ORPH)
-
ValueTheMarkets Podcast 032 - with Maurice Treacy, Chief Commercial Officer of Open Orphan (ORPH)
-
VIDEO: Open Orphan’s Maurice Treacy details pharma services firm’s ambitious growth plans in exclusive ValueTheMarkets presentation (ORPH)
-
Open Orphan – Consolidating the fragmented pharma services market (ORPH)